Winter and rainy season is worst for those who have low immunity. Antibiotics have many side effects. But there high fever due to viral infection is also risky.
A cold is an infection caused by a virus. It’s a common and usually mild illness that affects the nose and throat. Find out more here: http://bit.ly/KV8y1c.
The content is intended for general information only and does not replace the need for personal advice from a qualified health professional.
MONDAY, Dec. 19, 2022 (HealthDay News) — Patients with a high-risk bladder cancer now have a new option to treat it.
The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what’s called high-risk non-muscle-invasive bladder cancer (NMIBC) that hasn’t responded to the standard treatment, Bacillus Calmette-Guérin (BCG), but hasn’t spread. BCG is a vaccine typically used for tuberculosis.
“This approval provides health care professionals with an innovative treatment option for patients with high-risk NMIBC that is unresponsive to BCG therapy,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in an agency news release. “Today’s action addresses an area of critical need. The FDA remains committed to facilitating the development and approval of safe and effective cancer treatments.”
Researchers at the Wyss Institute at Harvard University have engineered the first-ever “Vagina on a Chip” in the world that replicates the human vaginal tissue microenvironment in vitro, Scientific American reported on Wednesday.
It is composed of the human vaginal epithelium and underlying connective tissue cells and it replicates many of the physiological features of the vagina, according to Harvard.
Best of all, it can be inoculated with different strains of bacteria allowing researchers to study their effects on the organ’s health.
Many investors are jumping to inject money into the startup.
Bill Gates and Jeff Bezos-backed foundations (Gates Frontier and Bezos Expeditions) have joined other companies in investing $75 million in Synchron, the endovascular brain-computer interface (BCI) company, according to a press release by the organization published on Thursday. This is a Series C financing round led by ARCH Venture Partners that brings the total amount raised since inception to $145 million.
Many investors on board.
Additional companies investing are Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors.
Synchron through Business Wire.
The funding will serve to support and promote the development of Synchron’s first platform product (Synchron Switch BCI), as well as the beginning of a pivotal clinical trial.
In this episode, filmed in early 2021, Sam and Peter discuss the creation of OpenAI and GPT-3, what the future of OpenAI will bring to humanity, and the power of AI/Human collaboration.
Sam Altman is the Co-Founder and CEO of OpenAI and former president of Y Combinator. OpenAI is an artificial intelligence research laboratory that creates programs, such as GPT-3, ChatGPT, and DALL-E 2, for the benefit of humanity.
Start using ChatGPT: https://chat.openai.com/
This episode is brought to you by Levels: real-time feedback on how diet impacts your health. https://levels.link/peter.
Consider a journey to optimize your mind and body by visiting http://mylifeforce.com/peter.
Read the Tech Blog: https://www.diamandis.com/blog.
What are #dopamine, #serotonin, norepinephrine, glutamate, #GABA, acetylcholine? What does dopamine do?
📢SUBSCRIBE and click the BELL to get notified when new videos are uploaded.
💲 AllCEUs.com Unlimited continuing education CEUs $59
💻 Online course based on this video can be found at AllCEUs.com/NEURO-CEU https://www.allceus.com/member/cart/index/product/id/96/c/
⭐ Specialty Certificate Programs for Case Management and Counselor Certification beginning at $89 https://AllCEUs.com/certificate-tracks.
Join this channel to get access to perks:
https://www.youtube.com/channel/UCAE3JJi8tX7gfhZEXCUGd_A/join.
NOTE: ALL VIDEOS are for educational purposes only and are NOT a replacement for medical advice or counseling from a licensed professional.
Video by Dr. Dawn Elise Snipes on integrative behavioral health approaches including counseling techniques and skills for improving mental health and reducing mental illness.
AllCEUs.com provides multimedia counselor education and CEUs for LPCs, LMHCs, LMFTs and LCSWs as well as addiction counselor precertification training and continuing education on many of the videos on this channel. Unlike other providers like CE4Less, AllCEUs includes a weekly LIVE Stream Webinar with your unlimited continuing education and professional development membership.
Objectives.
Leading Canada’s Bio-Safety & Security R&D — Dr. Loren Matheson PhD, Defence Research and Development Canada, Department of National Defence.
Dr. Loren Matheson, Ph.D. is a Portfolio Manager at the Center For Security Science, at Defence Research and Development Canada (DRDC — https://www.canada.ca/en/defence-research-development.html), which is a special operating agency of the Department of National Defence, whose purpose is to provide the Canadian Armed Forces, other government departments, and public safety and national security communities with knowledge and technology.
With a focus on the chemical and biological sciences at DRDC, Dr. Matheson develops and leads safety and security R&D projects with government partners, industry and academia. In addition, she spearheaded an effort to establish a virtual symposium series, developed communications products to explain their program to national and international partners, and helped established a science communication position.
Dr. Matheson previously served as both a senior science advisor within the Office of the Chief Science Operating Officer, and National Manager, Plant Health Research and Strategies, at the Canadian Food Inspection Agency.
After 10 years consulting as a grants facilitator in clinical research, Dr. Matheson moved to the public service to pursue interests in science policy and security science.
The rules will go into effect starting in 2023.
China has issued rules and guidelines that regulate the use of artificial intelligence within the country. The regulations are cautious when it comes to AI. This includes the trending AI chatbots, such as ChatGPT, AI-generated art, the many methods of utilizing AI in the health care sector and all forms of artificial intelligence, in general.
The Cyberspace Administration of China (CAC), has issued a set of rules to follow when incorporating AI. The CAC is the internet regulator and censor in China. The agency released guidelines on “deep synthesis”. The regulatory measures will take effect starting on Jan. 10, 2023.
Igor Kutyaev/iStock.
The conditions regarding AI, or “deep synthesis”.
Deep-learning models have proven to be highly valuable tools for making predictions and solving real-world tasks that involve the analysis of data. Despite their advantages, before they are deployed in real software and devices such as cell phones, these models require extensive training in physical data centers, which can be both time and energy consuming.
Researchers at Texas A&M University, Rain Neuromorphics and Sandia National Laboratories have recently devised a new system for training deep learning models more efficiently and on a larger scale. This system, introduced in a paper published in Nature Electronics, relies on the use of new training algorithms and memristor crossbar hardware, that can carry out multiple operations at once.
“Most people associate AI with health monitoring in smart watches, face recognition in smart phones, etc., but most of AI, in terms of energy spent, entails the training of AI models to perform these tasks,” Suhas Kumar, the senior author of the study, told TechXplore.
